136 related articles for article (PubMed ID: 36541248)
1. Laser-assisted depigmentation for vitiligo universalis: A retrospective monocentric study comparing nano- and picosecond lasers.
Martinez DA; Bertold C; Le Duff F; Bahadoran P; Passeron T
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e708-e710. PubMed ID: 36541248
[No Abstract] [Full Text] [Related]
2. Q-switched ruby laser for depigmentation: A feasible modality to treat vitiligo universalis in children.
Zhou Y; Gao T; Li C; Jian Z
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):115-117. PubMed ID: 37436020
[No Abstract] [Full Text] [Related]
3. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
Njoo MD; Vodegel RM; Westerhof W
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
[TBL] [Abstract][Full Text] [Related]
4. Depigmentation with Q-switched Nd:YAG laser in universal vitiligo: a long-term follow-up study of 4 years.
Majid I; Imran S
Lasers Med Sci; 2017 May; 32(4):851-855. PubMed ID: 28265789
[TBL] [Abstract][Full Text] [Related]
5. Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1,064/532 nm), cryotherapy and chemical peels: A comparative study.
El-Mofty M; Mostafa WZ; Esmat S; Zayed A; Mashaly H; Hussien MF; Ismail SI
Dermatol Ther; 2019 Sep; 32(5):e13052. PubMed ID: 31376312
[TBL] [Abstract][Full Text] [Related]
6. Q-switched laser depigmentation in vitiligo, most effective in active disease.
Komen L; Zwertbroek L; Burger SJ; van der Veen JP; de Rie MA; Wolkerstorfer A
Br J Dermatol; 2013 Dec; 169(6):1246-51. PubMed ID: 23909405
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and the adverse reactions of laser-assisted tattoo removal - a prospective split study using nanosecond and picosecond lasers.
Bäumler W; Breu C; Philipp B; Haslböck B; Berneburg M; Weiß KT
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):305-312. PubMed ID: 34543473
[TBL] [Abstract][Full Text] [Related]
8. Blue light-emitting diodes for the treatment of localized vitiligo: A retrospective study.
Lodi G; Del Re C; Nisticò SP; Bennardo L; Cannarozzo G; Sannino M
J Cosmet Dermatol; 2023 Apr; 22(4):1273-1278. PubMed ID: 36575871
[TBL] [Abstract][Full Text] [Related]
9. Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study.
Post NF; Rodrigues MA; Liong-A-Jin C; Lommerts A; Abdallah M; Bae JM; Bekkenk MW; Silva de Castro CC; Eleftheriadou V; Esmat S; Ezzedine K; van Geel N; Hamzavi I; Leone G; Pandya AG; Passeron T; Raboobee N; Seneschal J; Steven Th'ng ; Wolkerstorfer A
J Am Acad Dermatol; 2023 Aug; 89(2):352-354. PubMed ID: 36967022
[No Abstract] [Full Text] [Related]
10. Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial.
Ge Y; Yang Y; Guo L; Zhang M; Wu Q; Zeng R; Rong H; Jia G; Shi H; Fang J; Lin T
J Am Acad Dermatol; 2020 Aug; 83(2):397-403. PubMed ID: 30885760
[TBL] [Abstract][Full Text] [Related]
11. Platelet-rich plasma injection versus combined fractional carbon dioxide laser with platelet-rich plasma in treatment of vitiligo: A comparative study.
El-Mongy SE; Ghanem BM; El-Shrbeny YMME
J Cosmet Dermatol; 2023 May; 22(5):1699-1701. PubMed ID: 36606395
[No Abstract] [Full Text] [Related]
12. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
Yu S; Lan CE; Yu HS
Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
14. Picosecond 755-nm Alexandrite Lasers Are an Effective Treatment for Imatinib-Induced Hyperpigmentation.
Kok WL; Chua SH
Dermatol Surg; 2019 Apr; 45(4):616-618. PubMed ID: 30893177
[No Abstract] [Full Text] [Related]
15. Re-pigmentation of Hypopigmentation: Fractional Lasers vs Laser-Assisted Delivery of Bimatoprost vs Epidermal Melanocyte Harvesting System.
Waibel JS; Rudnick A; Arheart KL; Nagrani N; Gonzalez A; Gianatasio C
J Drugs Dermatol; 2019 Nov; 18(11):1090-1096. PubMed ID: 31738492
[TBL] [Abstract][Full Text] [Related]
16. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 311-nm Titanium:Sapphire laser and 308-nm excimer laser treatment for vitiligo: A randomized controlled non-inferiority trial.
Bae JM; Eun SH; Lee HN; Kim GM; Grimes PE; Lee JH
Lasers Surg Med; 2019 Mar; 51(3):239-244. PubMed ID: 30681166
[TBL] [Abstract][Full Text] [Related]
18. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis.
Kim YJ; Chung BS; Choi KC
Dermatol Surg; 2001 Nov; 27(11):969-70. PubMed ID: 11737134
[TBL] [Abstract][Full Text] [Related]
19. Q-switched laser therapy for recalcitrant and recurrent pigmentation after chemical depigmentation for extensive vitiligo.
Durham AB; Orringer JS
Dermatol Surg; 2012 Sep; 38(9):1563-5. PubMed ID: 22620980
[No Abstract] [Full Text] [Related]
20. A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians.
Chan JC; Shek SY; Kono T; Yeung CK; Chan HH
Lasers Surg Med; 2016 Jan; 48(1):23-9. PubMed ID: 26696500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
